SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-14-004197
Filing Date
2014-09-04
Accepted
2014-09-04 14:00:33
Documents
21
Period of Report
2014-09-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_090414.htm 8-K 27018
2 EXHIBIT 99.1 exh_991.htm EX-99.1 18005
3 exh991_01.jpg GRAPHIC 76403
4 exh991_02.jpg GRAPHIC 121955
5 exh991_03.jpg GRAPHIC 99365
6 exh991_04.jpg GRAPHIC 74521
7 exh991_05.jpg GRAPHIC 86575
8 exh991_06.jpg GRAPHIC 85963
9 exh991_07.jpg GRAPHIC 120013
10 exh991_08.jpg GRAPHIC 116097
11 exh991_09.jpg GRAPHIC 121287
12 exh991_10.jpg GRAPHIC 105937
13 exh991_11.jpg GRAPHIC 95825
14 exh991_12.jpg GRAPHIC 110630
15 exh991_13.jpg GRAPHIC 97835
16 exh991_14.jpg GRAPHIC 97701
17 exh991_15.jpg GRAPHIC 109747
18 exh991_16.jpg GRAPHIC 99050
19 exh991_17.jpg GRAPHIC 93383
20 exh991_18.jpg GRAPHIC 97552
21 exh991_19.jpg GRAPHIC 64310
  Complete submission text file 0001171843-14-004197.txt   2630710
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21214 | Film No.: 141082791
SIC: 2834 Pharmaceutical Preparations